ContraFect Corporation [NASDAQ: CFRX] jumped around 0.63 points on Tuesday, while shares priced at $5.75 at the close of the session, up 12.30%. The company report on November 13, 2020 that ContraFect Reports Third Quarter 2020 Financial Results and Provides Business Update.
CARB-X and Cystic Fibrosis Foundation grants provide significant additional funding to advance CF-370 for Pseudomonas aeruginosa infections.
Initiated expanded access program with exebacase for the treatment of persistent MRSA bloodstream infections in COVID-19 patients.
ContraFect Corporation stock is now -7.36% down from its year-to-date (YTD) trading value. CFRX Stock saw the intraday high of $5.75 and lowest of $5.1333 per share. The company’s 52-week high price is 13.40, which means current price is +29.21% above from all time high which was touched on 01/13/20.
Compared to the average trading volume of 156.74K shares, CFRX reached a trading volume of 1696856 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about ContraFect Corporation [CFRX]?
Mizuho have made an estimate for ContraFect Corporation shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 09, 2020. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on June 09, 2020, representing the official price target for ContraFect Corporation stock.
The Average True Range (ATR) for ContraFect Corporation is set at 0.31 The Price to Book ratio for the last quarter was 8.71, with the Price to Cash per share for the same quarter was set at 1.81.
How has CFRX stock performed recently?
ContraFect Corporation [CFRX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.48. With this latest performance, CFRX shares gained by 10.58% in over the last four-week period, additionally plugging by 8.29% over the last 6 months – not to mention a rise of 51.36% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CFRX stock in for the last two-week period is set at 60.62, with the RSI for the last a single of trading hit 64.76, and the three-weeks RSI is set at 56.94 for ContraFect Corporation [CFRX]. The present Moving Average for the last 50 days of trading for this stock 5.36, while it was recorded at 5.27 for the last single week of trading, and 6.16 for the last 200 days.
ContraFect Corporation [CFRX]: Deeper insight into the fundamentals
Return on Total Capital for CFRX is now -223.08, given the latest momentum, and Return on Invested Capital for the company is -105.08. Return on Equity for this stock declined to -121.35, with Return on Assets sitting at -37.70. When it comes to the capital structure of this company, ContraFect Corporation [CFRX] has a Total Debt to Total Equity ratio set at 25.06. Additionally, CFRX Total Debt to Total Capital is recorded at 20.04, with Total Debt to Total Assets ending up at 11.13. Long-Term Debt to Equity for the company is recorded at 21.00, with the Long-Term Debt to Total Capital now at 16.79.
Reflecting on the efficiency of the workforce at the company, ContraFect Corporation [CFRX] managed to generate an average of -$533,104 per employee.ContraFect Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 11.60 and a Current Ratio set at 11.60.
Earnings analysis for ContraFect Corporation [CFRX]
With the latest financial reports released by the company, ContraFect Corporation posted -1.11/share EPS, while the average EPS was predicted by analysts to be reported at -0.83/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -33.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CFRX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for ContraFect Corporation go to 12.70%.
Insider trade positions for ContraFect Corporation [CFRX]
There are presently around $90 million, or 62.60% of CFRX stock, in the hands of institutional investors. The top three institutional holders of CFRX stocks are: FEDERATED HERMES, INC. with ownership of 5,297,188, which is approximately 0% of the company’s market cap and around 8.77% of the total institutional ownership; BLACKROCK INC., holding 1,606,871 shares of the stock with an approximate value of $9.24 million in CFRX stocks shares; and BVF INC/IL, currently with $9.2 million in CFRX stock with ownership of nearly 0% of the company’s market capitalization.
Positions in ContraFect Corporation stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 39 institutional holders increased their position in ContraFect Corporation [NASDAQ:CFRX] by around 1,567,020 shares. Additionally, 13 investors decreased positions by around 1,249,741 shares, while 14 investors held positions by with 12,873,880 shares. The mentioned changes placed institutional holdings at 15,690,641 shares, according to the latest SEC report filing. CFRX stock had 13 new institutional investments in for a total of 569,791 shares, while 5 institutional investors sold positions of 177,438 shares during the same period.